Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
None
Efficacy and Safety of Pulsed Infusions of Levosimendan in Outpatients With Advanced Heart Failure

The purpose of this study is to compare the effects of a pulsed application of Levosimendan versus placebo on the composite end-point functional capacity and quality of life.

  • 36 views
  • 08 Nov, 2020
  • 7 locations
None
Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation

The purpose of this study is to accurately determine, using an implantable rhythm monitor, the long-term incidence of new atrial fibrillation after ablation of atrial flutter in those treated with spironolactone compared with standard medical therapy.

aldosterone
catheter ablation
electrocardiogram
heart failure
atrial flutter
  • 5 views
  • 26 Jan, 2021
  • 1 location
None
Vascular Healing After Implantation of FANTOM Bioresorbable Scaffold in STEMI: A FANTOM STEMI Study

The study will assess the safety and performance of the Fantom sirolimus eluting bioresorbable vascular scaffold (BVS) in the acute setting of myocardial infarction with unstable lesions and thrombogenic milieu.This is a prospective evaluation of clinical and patient related measures in STEMI patient who undergo urgent primary percutaneous coronary intervention …

  • 0 views
  • 22 Jan, 2021
  • 1 location
None
Sacubitril/Valsartan Versus Valsartan in Heart Failure With Improved Ejection Fraction

Heart failure (HF) is a chronic disease with weakened heart muscles or abnormal pressure within the heart chambers result in breathlessness, leg edema, or fatigue. A subclass of HF shows reduced heart muscle contractility, which is represented by the left ventricular ejection fraction (LVEF). Valsartan is an angiotensin II receptor …

  • 0 views
  • 28 Aug, 2021
  • 1 location
None
Outcome of Patients With Primary Aldosteronism

Majority of patients with hypertension have primary hypertension (without an underlying cause). Primary aldosteronism (PA) is the most common cause of secondary hypertension, and can be found in 5-10% of patients locally. PA is caused by excessive release of a hormone (aldosterone) from the adrenal glands, which can be unilateral …

cardiovascular morbidity
aldosterone
adrenalectomy
hypertension
essential hypertension
  • 0 views
  • 22 Aug, 2021
  • 1 location
None
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.

Study is conducted to assess the prevalence and structure of comorbidity among patients undergoing abdominal surgery and produce the stratification of the risk of postoperative complications by identifying independent predictors for its development.

  • 65 views
  • 10 Apr, 2021
  • 42 locations
None
CCM Italian Registry

The Cardiac Contractility Modulation (CCM) system is a cardiac implantable device indicated for the treatment of patients with symptomatic heart failure with left ventricular systolic dysfunction despite optimal medical and electrical therapy. This system consists of a generator to which two stimulation leads are connected, which are fixed on the …

left ventricular systolic dysfunction
beta-adrenergic blocking agents
medical therapy
heart failure
systolic dysfunction
  • 0 views
  • 24 Jan, 2021
  • 1 location